SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Windlas Biotech informs about analyst meet

11 Jan 2022 Evaluate

Windlas Biotech has informed about schedule of Analyst/ Institutional Investor meetings on 11th January 2022 under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.

The above information is a part of company’s filings submitted to BSE.

Windlas Biotech Share Price

861.00 -34.70 (-3.87%)
24-Apr-2026 09:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1645.65
Dr. Reddys Lab 1326.95
Cipla 1286.70
Zydus Lifesciences 938.00
Lupin 2327.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×